Burlington, Mass.-based Arcadia Healthcare Solutions received $30 million in capital growth investments.
New investors include Merck Global Health Innovation Fund and GE Ventures. Previous investors include Peloton Equity, Zaffre Investments and Morgan Stanley Alternative Investment Partners. The investment will fund development plans in the company's Arcadia Analytics platform and extend population health management market activities nationwide.
Arcadia is an EHR data aggregation and analytics technology company with more than 60 customers. Arcadia focuses on serving ambulatory networks affiliated with larger provider and payer organizations like ACOs, health plans, integrated delivery networks and large independent physician groups.
"Having Merck GHI and GE Ventures join existing investors in this round of growth capital is the optimal outcome for us," Arcadia CEO Sean Carroll said in a statement. "The rigorous process expands our team of blue chip investors who actively support their companies' growth plans."
More articles on health IT:
Study: Video games may improve mood, function in late life depression patients
Illumina taps IBM Watson for cancer data interpretation
Survey: 49% of health IT professionals worry about inappropriate employee use of mobile devices